Argonaute Rna

Provider of RNA-based therapeutics

placeBristol, England, United Kingdom calendar_todayFounded 2015 groups7 employees language argonauterna.com

Registered entities

Innovation

39 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 248 times.

YearFilings
20192
202012
20218
20227
20239
202413
20255
20262

Investor mix

51 investors on record; lead investors include Development Bank of Wales.

Investor typeCountShare
Venture capital24%
Private equity36%
Angel & family office12%
Accelerator & incubator12%
Other / undisclosed4486%
Coming soon